← Back
$ANTX All transactions

AN2 Therapeutics, Inc.

A

$ Value

$0

Shares

3,775

Price

$0

Filed

Apr 10

Insider

Name

Marks Gilbert Lynn

Title

CIK

0001916940

Roles

Director

Transaction Details

Transaction Date

2026-04-10

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

79,084

Footnotes

Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.

Filing Info

Accession No.

0001193125-26-151628

Form Type

4

Issuer CIK

0001880438

Marks Gilbert Lynn's History

Date Ticker Type Value
2026-04-10 ANTX A $0
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-02-20 ANTX A $0
2026-01-12 ANTX A $0
2025-10-10 ANTX A $0

Other Insiders at ANTX (90d)

Insider Bought Sold Last
Zakrzewski Joseph S 2026-03-19
Spigelman Melvin K 2026-03-19
Wong Stephanie 2026-03-19
Chanda Sanjay
Chief Development Officer
2026-03-19
FitzPatrick Margaret M 2026-03-19
Easom Eric
Chief Executive Officer
2026-03-19
Day Lucy
Chief Financial Officer
2026-03-19
Aziz Kabeer 2026-04-10
Readnour Robin Shane 2026-03-19
Martin Patricia A. 2026-04-10
Marks Gilbert Lynn 2026-03-19
Eizen Joshua M
See Remarks
2026-03-19
Williams Sarah Joanne
Principal Accounting Officer
$347 2026-03-03